# Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study

> **NCT06069505** · — · RECRUITING · sponsor: **Bart Rijnders** · enrollment: 300 (estimated)

## Conditions studied

- Invasive Aspergillosis

## Interventions

- **DIAGNOSTIC_TEST:** Aspergillus PCR

## Key facts

- **NCT ID:** NCT06069505
- **Lead sponsor:** Bart Rijnders
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-07-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069505, "Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06069505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*